Somatic Mutations and Deletions of the E-Cadherin Gene Predict Poor Survival of Patients With Gastric Cancer

作者: Giovanni Corso , Joana Carvalho , Daniele Marrelli , Carla Vindigni , Beatriz Carvalho

DOI: 10.1200/JCO.2012.44.4612

关键词: ImmunohistochemistryBiologyMutationGermlineSomatic cellCancer researchCDH1Loss of heterozygosityCancerDNA methylation

摘要: Purpose The prognosis of gastric cancer (GC) is poor, and the molecular pathogenesis players are vastly unknown. Surgery remains primary option in GC treatment. aim this study was to investigate impact somatic CDH1 alterations survival patients with GC. Patients Methods A series sporadic familial (diffuse intestinal; n = 246) were analyzed for mutations, promoter hypermethylation, loss heterozygosity (LOH) by polymerase chain reaction sequencing. E-cadherin protein expression determined immunohistochemistry. Associations between molecular, clinicopathologic, data analyzed. Results found approximately 30% all Both histologic types displayed LOH 7.5%, mutations 1.7%, hypermethylation 18.4% patients. Primary tumors from hereditary diffuse GC, lacking germline alterations, showed exclusively hy...

参考文章(48)
J. Simoes-Correia, J. Figueiredo, C. Oliveira, J. van Hengel, R. Seruca, F. van Roy, G. Suriano, Endoplasmic Reticulum Quality Control: a new mechanism of E-cadherin regulation and its implication in cancer Human Molecular Genetics. ,vol. 17, pp. 3566- 3576 ,(2008) , 10.1093/HMG/DDN249
A.E. Dassen, V.E.P.P. Lemmens, L.V. van de Poll-Franse, G.J. Creemers, S.J. Brenninkmeijer, D.J. Lips, A.A.M. vd Wurff, K. Bosscha, J.W.W. Coebergh, Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: A population-based study in the Netherlands European Journal of Cancer. ,vol. 46, pp. 1101- 1110 ,(2010) , 10.1016/J.EJCA.2010.02.013
David Cunningham, William H Allum, Sally P Stenning, Jeremy N Thompson, Cornelis JH Van de Velde, Marianne Nicolson, J Howard Scarffe, Fiona J Lofts, Stephen J Falk, Timothy J Iveson, David B Smith, Ruth E Langley, Monica Verma, Simon Weeden, YKS Viswanath Chua, Yu Jo, MAGIC Trial participants, Nick Wadd, None, Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer The New England Journal of Medicine. ,vol. 355, pp. 11- 20 ,(2006) , 10.1056/NEJMOA055531
Walter Birchmeier, Friedrich W. Schildberg, Ilona Funke, Markus M. Heiss, Judith P. Johnson, Barbara Mayer, Florian Leitl, Karl W. Jauch, E-Cadherin Expression in Primary and Metastatic Gastric Cancer: Down-Regulation Correlates with Cellular Dedifferentiation and Glandular Disintegration Cancer Research. ,vol. 53, pp. 1690- 1695 ,(1993)
C. Oliveira, J. Senz, P. Kaurah, H. Pinheiro, R. Sanges, A. Haegert, G. Corso, J. Schouten, R. Fitzgerald, H. Vogelsang, G. Keller, S. Dwerryhouse, D. Grimmer, S.-F. Chin, H.-K. Yang, C. E. Jackson, R. Seruca, F. Roviello, E. Stupka, C. Caldas, D. Huntsman, Germline CDH1 deletions in hereditary diffuse gastric cancer families Human Molecular Genetics. ,vol. 18, pp. 1545- 1555 ,(2009) , 10.1093/HMG/DDP046
M Barber, A Murrell, Y Ito, A-T Maia, S Hyland, C Oliveira, V Save, F Carneiro, AL Paterson, N Grehan, S Dwerryhouse, P Lao-Sirieix, C Caldas, RC Fitzgerald, Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. The Journal of Pathology. ,vol. 216, pp. 295- 306 ,(2008) , 10.1002/PATH.2426
Francesco Graziano, Federica Arduini, Annamaria Ruzzo, Italo Bearzi, Bostjan Humar, Helen More, Rosarita Silva, Pietro Muretto, Parry Guilford, Enrica Testa, Davide Mari, Mauro Magnani, Stefano Cascinu, Prognostic Analysis of E-Cadherin Gene Promoter Hypermethylation in Patients with Surgically Resected, Node-Positive, Diffuse Gastric Cancer Clinical Cancer Research. ,vol. 10, pp. 2784- 2789 ,(2004) , 10.1158/1078-0432.CCR-03-0320
Gen Tamura, Jing Yin, Suna Wang, A Steven Fleisher, Tongtong Zou, John M Abraham, Dehe Kong, Kara N Smolinski, Keith T Wilson, Stephen P James, Steven G Silverberg, Satoshi Nishizuka, Masanori Terashima, Teiichi Motoyama, Stephen J Meltzer, E-Cadherin Gene Promoter Hypermethylation in Primary Human Gastric Carcinomas Journal of the National Cancer Institute. ,vol. 92, pp. 569- 573 ,(2000) , 10.1093/JNCI/92.7.569
Christoph Schuhmacher, Stephan Gretschel, Florian Lordick, Peter Reichardt, Werner Hohenberger, Claus F. Eisenberger, Cornelie Haag, Murielle E. Mauer, Baktiar Hasan, John Welch, Katja Ott, Arnulf Hoelscher, Paul M. Schneider, Wolf Bechstein, Hans Wilke, Manfred P. Lutz, Bernard Nordlinger, Eric Van Cutsem, Jörg R. Siewert, Peter M. Schlag, Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. Journal of Clinical Oncology. ,vol. 28, pp. 5210- 5218 ,(2010) , 10.1200/JCO.2009.26.6114
Alberto Biondi, Roberto Persiani, Ferdinando Cananzi, Marco Zoccali, Vincenzo Vigorita, Andrea Tufo, Domenico D’Ugo, R0 resection in the treatment of gastric cancer: Room for improvement World Journal of Gastroenterology. ,vol. 16, pp. 3358- 3370 ,(2010) , 10.3748/WJG.V16.I27.3358